Clinical trial
Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
NCT03895437
Study timeline
Study start (actual)2019-06-17Date precision: day
Registry last updated2026-05-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
TOL-3021BIOLOGICAL
TOL-3021 PlaceboOTHER
Sponsors & collaborators
Tolerion, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San AntonioTexas, United States1San FranciscoCalifornia, United States1San DiegoCalifornia, United States1TampaFlorida, United States1JacksonvilleFlorida, United States1DenverColorado, United States1New HavenConnecticut, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03895437 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.